In the past nine issues of this newsletter, we have listed under this heading information regarding the fulfilment of certain indicators. Finally, we got even to those publications. 😊
At the very beginning of the project, NICR has declared its intention to generate at least 630 classifiable outputs, of which over 400 would be published. The ambition was to publish 65% of contributions in journals of the first quartile (Q1) of the relevant area according to the Web of Science. NICR managed to not only meet but exceed these targets.
Works by researchers from teams participating in NICR were published by numerous renowned journals including Nature, Nature Communications, PNAS, Leukemia, Blood Advances, Nucleic Acid Research, Journal of Clinical Investigation, Clinical Cancer Research, Angewandte Chemie, Journal of Experimental Medicine, EMBO J, Molecular Cancer, and others.
| 790+ | JIMP publications |
| 550+ | Q1 publications |
| 180+ | D1 publications |
| 330+ | Publications resulting from inter-regional cooperation |
| 360+ | Publications resulting from collaboration with researchers from abroad |
Overall data for 2022 and 2025 have been approximated.
For 2025, classification of Q1 and D1 is based on JCR – Clarivate evaluation for the preceding year.